DOPATREE
Preview
Open in TheBrain
DOPATREE
STUDIES
STUDIES / RELATED
PROTOCOL DEVELOPMENT (CLINICAL STUDY DESIGNS, ENDPOINTS, CLINICAL TRIALS, NON-INFERIORITY, SUPERIORITY, NONINFERIORITY, COHORTS, EFFICACY, SAFETY, EFFECTIVENESS)
PROTOCOL DEVELOPMENT / LAWS AND REGULATIONS / US
Parents
PROTOCOL DEVELOPMENT (CLINICAL STUDY DESIGNS, ENDPOINTS, CLINICAL TRIALS, NON-INFERIORITY, SUPERIORITY, NONINFERIORITY, COHORTS, EFFICACY, SAFETY, EFFECTIVENESS)
Children
US FDA. DRAFT GUIDANCE. INBORN ERRORS OF METABOLISM THAT USE DIETARY MANAGEMENT : CONSIDERATIONS FOR OPTIMIZING AND STANDARDIZING DIET IN CLINICAL TRIALS FOR DRUG PRODUCT DEVELOPMENT. JUL 2018.
US FDA. DRAFT GUIDELINE. M11 CLINICAL ELECTRONIC STRUCTURED HARMONISED PROTOCOL (CESHARP). SEP 27, 2022.
US FDA. DRAFT GUIDELINE. M11 TECHNICAL SPECIFICATION. CLINICAL ELECTRONIC STRUCTURED HARMONISED PROTOCOL (CESHARP). SEP 27, 2022.
US FDA. DRAFT GUIDELINE. M11 TEMPLATE. CLINICAL ELECTRONIC STRUCTURED HARMONISED PROTOCOL (CESHARP). SEP 27, 2022.
US FDA. GUIDANCE. ANTIBACTERIAL DRUG PRODUCTS : USE OF NONINFERIORITY TRIALS TO SUPPORT APPROVAL. NOV 2010.
US FDA. GUIDANCE. DRUG STUDY DESIGNS. JAN 01, 1998.
US FDA. GUIDANCE. E10 CHOICE OF CONTROL GROUP AND RELATED ISSUES IN CLINICAL TRIALS. MAY 14, 2001.
US FDA. GUIDANCE. E7 STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS. QUESTIONS AND ANSWERS. FEB 2012.
US FDA. GUIDANCE. ESTIMATING THE MAXIMUM SAFE STARTING DOSE IN INITIAL CLINICAL TRIALS FOR THERAPEUTICS IN ADULT HEALTHY VOLUNTEERS. JUL 28, 2005.
US FDA. GUIDANCE. EVALUATION OF GENDER DIFFERENCES IN CLINICAL INVESTIGATIONS. JAN 01, 1998.
US FDA. GUIDANCE. EXPANSION COHORTS : USE IN FIRST-IN-HUMAN CLINICAL TRIALS TO EXPEDITE DEVELOPMENT OF ONCOLOGY DRUGS AND BIOLOGICS. MAR 2022.
US FDA. GUIDANCE. INTERACTING WITH THE FDA ON COMPLEX INNOVATIVE TRIAL DESIGNS FOR DRUGS AND BIOLOGICAL PRODUCTS. DEC 2020.
US FDA. GUIDANCE. NON-INFERIORITY CLINICAL TRIALS TO ESTABLISH EFFECTIVENESS. NOV 2016.
US FDA. GUIDANCE. PROVIDING CLINICAL EVIDENCE OF EFFECTIVENESS FOR HUMAN DRUG AND BIOLOGICAL PRODUCTS.. MAY 15, 1998.